Ovid Therapeutics Inc. (OVID) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Ovid Therapeutics Inc. (OVID) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

OVID Income Statement

Ovid Therapeutics Inc. (OVID) annual income statement — 12-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	733K	0	718K	132K	6.27M	130K	76K	173K	169K	148K	142K	109K	75K	66K	46.28K	11.1K	0	1.45M	0	0
Revenue Growth %	-88.31%	-100%	844.74%	-23.7%	3611.24%	-12.16%	-46.48%	58.72%	125.33%	124.24%	206.83%	881.81%	-	-95.43%	-	-	-	-99.31%	-100%	-100%
Cost of Goods Sold	0	35K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56.87K	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	733K	-35K	718K	132K	6.27M	130K	76K	173K	169K	148K	142K	109K	75K	66K	46.28K	11.1K	0	1.45M	-56.87K	0
Gross Margin %	100%	-	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	-	100%	-	-
Gross Profit Growth %	-88.31%	-126.92%	844.74%	-23.7%	3611.24%	-12.16%	-46.48%	58.72%	125.33%	124.24%	206.83%	881.81%	-	-95.43%	181.38%	-	-	-99.31%	-101%	-100%
Operating Expenses	16.43M	17.81M	13.01M	12.65M	11.35M	12.68M	10.8M	13.4M	20.69M	17.57M	18.33M	12.14M	14.25M	14.96M	12.22M	12.81M	14.3M	17.71M	26.3M	11.68M
OpEx % of Revenue	2241.61%	-	1812.12%	9587.12%	180.88%	9753.85%	14207.89%	7745.09%	12240.24%	11868.24%	12908.45%	11135.78%	18996%	22663.64%	26402.75%	115429.27%	-	1225.47%	-	-
Selling, General & Admin	6.17M	6.67M	6.42M	6.79M	4.88M	6.02M	6.78M	5.54M	8.1M	7.17M	6.19M	6.8M	7.25M	8.34M	7.36M	7.63M	8.26M	9.88M	8.23M	6.76M
SG&A % of Revenue	842.29%	-	894.43%	5140.15%	77.81%	4631.54%	8914.47%	3204.62%	4795.27%	4843.24%	4357.75%	6243.12%	9664%	12642.42%	15909.65%	68744.37%	-	683.56%	-	-
Research & Development	9.96M	11.15M	6.59M	5.87M	6.46M	6.66M	5.92M	7.86M	12.58M	10.4M	10.64M	5.33M	6M	6.62M	5.56M	5.18M	6.05M	7.83M	18.07M	4.92M
R&D % of Revenue	1358.39%	-	917.69%	4446.97%	103.08%	5122.31%	7793.42%	4540.46%	7444.97%	7025%	7494.37%	4892.66%	7998.67%	10022.73%	12005.63%	46687.56%	-	541.89%	-	-
Other Operating Expenses	300K	0	0	0	0	0	-1000K	0	1	0	1000K	0	1000K	-999	-700K	-295	617	203	0	341
Operating Income	-15.7M	-17.85M	-12.29M	-12.52M	-5.07M	-12.55M	-10.72M	-13.23M	-20.52M	-17.42M	-18.19M	-12.03M	-14.17M	-14.89M	-12.17M	-12.8M	-14.3M	-16.27M	-26.35M	-11.68M
Operating Margin %	-2141.61%	-	-1712.12%	-9487.12%	-80.88%	-9653.85%	-14107.89%	-7645.09%	-12140.24%	-11768.24%	-12808.45%	-11035.78%	-18896%	-22563.64%	-26302.75%	-115329.27%	-	-1125.47%	-	-
Operating Income Growth %	-209.44%	-42.2%	-14.65%	5.32%	75.27%	27.94%	41.05%	-9.95%	-44.77%	-16.96%	-49.41%	6.05%	0.92%	8.45%	53.81%	-9.61%	0.06%	-109.21%	-22.06%	28.79%
EBITDA	-15.68M	-17.81M	-12.28M	-12.51M	-4.97M	-12.41M	-10.56M	-13.06M	-20.37M	-17.28M	-18.05M	-11.88M	-14.04M	-14.75M	-11.99M	-12.39M	-13.85M	-16.19M	-26.3M	-11.63M
EBITDA Margin %	-2139.43%	-	-1709.75%	-9475%	-79.3%	-9545.38%	-13897.37%	-7547.4%	-12052.66%	-11676.35%	-12709.86%	-10901.83%	-18713.33%	-22343.94%	-25903.05%	-111587.92%	-	-1120.36%	-	-
EBITDA Growth %	-215.28%	-43.53%	-16.23%	4.21%	75.58%	28.19%	41.48%	-9.88%	-45.13%	-17.18%	-50.55%	4.08%	-1.32%	8.93%	54.41%	-6.53%	2.86%	-109.17%	-22.26%	28.76%
D&A (Non-Cash Add-back)	16K	35K	17K	16K	99K	141K	160K	169K	148K	136K	140K	146K	137K	145K	184.98K	415.37K	452.48K	73.81K	56.87K	52.18K
EBIT	-15.4M	-16.99M	9.66M	-12.16M	-4.68M	-10.23M	-10.92M	-14.01M	8.52M	-11.69M	-16.49M	-12.03M	-13.17M	-14.89M	-12.87M	-12.8M	-14.3M	-16.27M	-26.35M	-11.68M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	689K	858K	21.96M	365K	389K	2.31M	1.47M	-780K	29.04M	5.72M	2.87M	776K	1.76M	1.54M	668.12K	836.09K	-284.13K	209.05K	3.9K	2.66K
Pretax Income	-15.01M	-16.99M	9.66M	-12.16M	-4.68M	-10.23M	-9.25M	-14.01M	8.52M	-11.69M	-15.32M	-11.25M	-12.41M	-13.36M	-11.5M	-11.97M	-14.59M	-16.06M	-26.35M	-11.68M
Pretax Margin %	-2047.61%	-	1345.82%	-9210.61%	-74.68%	-7873.08%	-12175%	-8095.95%	5042.01%	-7901.35%	-10790.14%	-10323.85%	-16544%	-20236.36%	-24859.09%	-107798.33%	-	-1111%	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50K	-349.71K	-294.83K
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	-0.31%	1.33%	2.52%
Net Income	-15.01M	-16.99M	9.66M	-12.16M	-4.68M	-10.23M	-9.25M	-14.01M	8.52M	-11.69M	-15.32M	-11.25M	-12.41M	-13.36M	-11.5M	-11.97M	-14.59M	-16.11M	-25.15M	-11.38M
Net Margin %	-2047.61%	-	1345.82%	-9210.61%	-74.68%	-7873.08%	-12175%	-8095.95%	5042.01%	-7901.35%	-10790.14%	-10323.85%	-16544%	-20236.36%	-24859.09%	-107798.33%	-	-1114.46%	-	-
Net Income Growth %	-220.43%	-65.98%	204.43%	13.19%	-154.97%	12.48%	39.61%	-24.46%	168.67%	12.44%	-33.18%	5.97%	14.95%	17.09%	54.26%	-5.13%	7.6%	-109.15%	-14.17%	30.69%
Net Income (Continuing)	-15.01M	-16.99M	9.66M	-12.16M	-4.68M	-10.23M	-9.25M	-14.01M	8.52M	-11.69M	-15.32M	-11.25M	-12.41M	-13.36M	-11.5M	-11.97M	-14.59M	-16.11M	-26M	-11.38M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.20	-0.23	0.12	-0.17	-0.07	-0.14	-0.13	-0.20	0.12	-0.17	-0.22	-0.16	-0.18	-0.19	-0.16	-0.16	-0.21	-0.23	-0.38	-0.17
EPS Growth %	-203.49%	-64.29%	192.31%	15%	-154.92%	17.65%	40.91%	-25%	166.67%	10.53%	-37.5%	0%	14.29%	17.39%	57.89%	5.88%	8.7%	-109.09%	-11.76%	39.29%
EPS (Basic)	-0.20	-0.23	0.12	-0.17	-0.07	-0.14	-0.13	-0.20	0.12	-0.17	-0.22	-0.16	-0.18	-0.19	-0.16	-0.16	-0.21	-0.23	-0.38	-0.17
Diluted Shares Outstanding	73.74M	73.74M	81.67M	71.11M	71.11M	71.05M	71.01M	70.98M	71.2M	70.72M	70.69M	70.62M	70.53M	70.49M	70.47M	70.43M	70.39M	70.35M	68.16M	67.93M
Basic Shares Outstanding	73.74M	73.74M	81.67M	71.11M	71.11M	71.05M	71.01M	70.98M	70.92M	70.72M	70.69M	70.62M	70.53M	70.3M	70.47M	70.4M	69.47M	70.03M	67.51M	66.97M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-